You have 9 free searches left this month | for more free features.

Sepsis-3

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sepsis-3 Study in Northeast Thailand

Recruiting
  • Sepsis
  • Community-Acquired Infections
  • Specimens collection
  • Ubon Ratchathani, Thailand
    Sappasithiprasong Hospital
Aug 1, 2022

HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis

Not yet recruiting
  • Sepsis
  • nothing
  • Tianjin, Tianjin, China
    Tianjin Nankai Hospital
Sep 13, 2023

Practical Cinical UTility of NuQ.® H3.1 Nucleosome Levels in

Not yet recruiting
  • Sepsis
  • NuQ H3.1 Nucleosome Assay
  • London, United Kingdom
    Guy's & St Thomas' NHS Foundation Trust
Jun 19, 2023

Circulatory Shock and Sepsis (MiMICSS)

Recruiting
  • Sepsis
  • +2 more
  • Skeletal muscle and cerebral NIRS (research device)
  • Winnipeg, Manitoba, Canada
    Health Sciences Centre Winnipeg
Aug 2, 2023

INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in

Recruiting
  • Sepsis
  • Blood collection
  • Toulouse, France
    University Hospital of Toulouse
Jun 8, 2022

Sepsis, ARDS, Critical Illness Trial in London (Phelebotomy, Broncheoalveolar Lavage)

Not yet recruiting
  • Sepsis
  • +8 more
  • Phelebotomy
  • Broncheoalveolar Lavage
  • London, Ontario, Canada
    Aleks Leligdowicz
Oct 25, 2022

CRP and PCT as Predictors of Sepsis Cause

Not yet recruiting
  • Sepsis
  • +2 more
  • PCT levels
  • +3 more
  • Osijek, Croatia
    University Hospital Osijek
Oct 30, 2022

Neonatal Sepsis Trial in Worldwide (Ceftobiprole medocaril)

Recruiting
  • Neonatal Sepsis
  • Ceftobiprole medocaril
  • Los Angeles, California
  • +14 more
May 3, 2023

NGS-Based Assay of Blood Samples of Sepsis Rapid Bacterial

Recruiting
  • Pneumonia
  • +3 more
  • NGS-based assay for bacterial identification
  • Chaïdári, Attiki, Greece
  • +3 more
Nov 21, 2023

Sepsis Trial in United Kingdom (Prevenar 13, Sodium Chloride 0.9%)

Active, not recruiting
  • Sepsis
  • Prevenar 13
  • Sodium Chloride 0.9%
  • Belfast, United Kingdom
  • +11 more
Dec 12, 2022

Sepsis Trial in Cairo (Vitamin D3 tablets, Vitamin D tablets)

Recruiting
  • Sepsis
  • Vitamin D3 tablets
  • Vitamin D tablets
  • Cairo, Egypt
    Ain-Shams University Hospitals
Apr 13, 2022

Postpartum Sepsis, Postpartum Endometritis, Postpartum Fever Trial in Bamenda (Azithromycin, Azithromycin and amoxicillin,

Completed
  • Postpartum Sepsis
  • +2 more
  • Bamenda, Cameroon
    Cameroon Baptist Convention Health Services
Mar 18, 2022

Sidestream Dark-Field Imaging of Intestinal Microcirculation

Active, not recruiting
  • Sepsis
    • Halifax, Nova Scotia, Canada
      Queen Elizabeth II Health Sciences Cetnre
    Mar 7, 2022

    Septic Shock Trial in Calgary (Therapeutic plasma exchange)

    Recruiting
    • Septic Shock
    • Therapeutic plasma exchange
    • Calgary, Alberta, Canada
    • +1 more
    Feb 15, 2022

    Acute Kidney Injury, Sepsis Trial in Foshan (Standard Reagents, Whole Blood)

    Recruiting
    • Acute Kidney Injury
    • Sepsis
    • Standard Reagents, Whole Blood
    • Foshan, China
      Critical Care Department, First People's Hospital of Foshan
    Jan 19, 2023

    Septic Shock, Vasodilatory Shock Trial in Albuquerque (Angiotensin II)

    Recruiting
    • Septic Shock
    • Vasodilatory Shock
    • Angiotensin II
    • Albuquerque, New Mexico
      University of New Mexico Health Sciences Center
    Apr 19, 2023

    Severe Intra-abdominal Sepsis Managed With Laparostomy and

    Completed
    • Abdominal Sepsis
      • Thessaloniki, Greece
        3rd Department of Surgery, AHEPA University Hospital
      Aug 25, 2021

      Children After Hospitalization in Intensive Care Unit

      Not yet recruiting
      • Renal Disease
      • +7 more
      • neurocognitive tests
      • Calgary, Alberta, Canada
      • +7 more
      Nov 3, 2023

      Sepsis, Sepsis-induced Coagulopathy, Nafamostat Mesilate Trial (Nafamostat mesilate, 5% glucose)

      Not yet recruiting
      • Sepsis
      • +2 more
      • Nafamostat mesilate
      • 5% glucose
      • (no location specified)
      Oct 5, 2023

      Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)

      Not yet recruiting
      • Staphylococcus Aureus Bacteremia
      • +3 more
      • Montreal, Quebec, Canada
        McGill University Health Centre (Royal Victoria Hospital and Mon
      Feb 21, 2022

      CLABSI - Central Line Associated Bloodstream Infection Trial in Baltimore (Sodium Citrate 4% Inj Syringe 3Ml)

      Recruiting
      • CLABSI - Central Line Associated Bloodstream Infection
      • Sodium Citrate 4% Inj Syringe 3Ml
      • Baltimore, Maryland
        Johns Hopkins
      Oct 12, 2022

      Sepsis, Severe Sepsis, End Organ Damage Trial in Boston (vitamin D3, Placebo)

      Withdrawn
      • Sepsis
      • +3 more
      • vitamin D3
      • Placebo
      • Boston, Massachusetts
        Massachusetts General Hospital
      Apr 30, 2021

      Multi-Drug Resistant Organisms, Late-Onset Sepsis, Neonatal, Antimicrobial Resistance Trial in Edmonton (Exposure of interest)

      Recruiting
      • Multi-Drug Resistant Organisms
      • +2 more
      • Exposure of interest
      • Edmonton, Alberta, Canada
        Royal Alexandra Hospital
      Dec 7, 2021

      Gastroenteritis, Bronchiolitis, Sepsis Trial in Montreal (0.9% saline in 5% dextrose (intravenous), 0.45% saline in 5% dextrose

      Completed
      • Gastroenteritis
      • +3 more
      • 0.9% saline in 5% dextrose (intravenous)
      • 0.45% saline in 5% dextrose (intravenous)
      • Montreal, Quebec, Canada
        Montreal Children's Hospital
      Apr 4, 2022

      Sepsis Trial in Worldwide (Anakinra or rhIFN?, Placebo)

      Recruiting
      • Sepsis
      • Anakinra or rhIFNγ
      • Placebo
      • Jena, Germany
      • +25 more
      Jul 13, 2022